Earnings Preview For Capricor Therapeutics
Earnings Preview For Capricor Therapeutics
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.Capricor Therapeutics (NASDAQ:CAPR) is gearing up to announce its quarterly earnings on Wednesday, 2024-11-13. Here's a quick overview of what investors should know before the release.
capricor therapeutics（纳斯达克：CAPR）正准备在2024年11月13日星期三公布季度财报。在发布之前，这里是投资者应该了解的内容概览。
Analysts are estimating that Capricor Therapeutics will report an earnings per share (EPS) of $-0.36.
分析师预计Capricor Therapeutics的每股收益（EPS）为-0.36美元。
Investors in Capricor Therapeutics are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
Capricor Therapeutics的投资者们正急切地期待公司的公告，希望能够听到超过预期的消息，并对下个季度做出积极引导。
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
值得新投资者注意的是，股票价格往往受未来预期的影响，而不仅仅是过去的业绩。
Historical Earnings Performance
历史业绩表现
During the last quarter, the company reported an EPS beat by $0.01, leading to a 8.99% increase in the share price on the subsequent day.
在上一个季度，该公司报告每股收益超出0.01美元，导致随后一天股价上涨了8.99%。
Here's a look at Capricor Therapeutics's past performance and the resulting price change:
这是Capricor Therapeutics过去表现和随之而来的价格变化。
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.36 | -0.11 | -0.09 | -0.29 |
| EPS Actual | -0.35 | -0.31 | -0.02 | -0.25 |
| Price Change % | 9.0% | -4.0% | 9.0% | 7.000000000000001% |
| 季度 | 2024年第二季度 | Q1 2024 | 2023年第四季度 | 2023年第三季度 |
|---|---|---|---|---|
| 每股收益预估值 | -0.36 | -0.11 | -0.09 | -0.29 |
| 每股收益实际值 | -0.35 | -0.31 | -0.02 | -0.25 |
| 价格变更% | 9.0% | -4.0% | 9.0% | 7.000000000000001% |
Performance of Capricor Therapeutics Shares
Capricor Therapeutics股价表现
Shares of Capricor Therapeutics were trading at $19.54 as of November 11. Over the last 52-week period, shares are up 508.72%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release.
截至11月11日，Capricor Therapeutics的股价为$19.54。在过去的52周中，股价上涨了508.72%。鉴于这些回报通常是积极的，长期股东在这份财报公布前应该感到满意。
To track all earnings releases for Capricor Therapeutics visit their earnings calendar on our site.
要追踪Capricor Therapeutics的所有财报，请访问我们网站上的财报日历。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文是由Benzinga的自动内容引擎生成，并由编辑审核。
